Brain Serotonin, Carbohydrate-Craving, Obesity and Depression
Serotonin in the brain, and perhaps elsewhere, is involved in mechanisms that affect macronutrient selection, generate feelings of satiety, and, if malfunctioning, predispose to obesity. Drugs which increase the quantities of serotonin present within synapses can cause weight reduction. Such drugs presently include those that release the neurotransmitter by a direct action on nerve terminals (e.g., dexfenfluramine’s metabolite dexnorfenfluramine) or by activating serotoninergic neurons (e.g., nicotine); by activating post-synaptic serotonin receptors (e.g., dexnorfenfluramine); or by prolonging serotonin’s existence within synapses by blocking its reuptake (e.g., dexfenfluramine; fluoxetine, sertraline; paroxetine). Additional ways are known by which intrasynaptic serotonin levels can be augmented (e.g. increasing its synthesis with tryptophan; inhibiting its destruction by monoamine oxidase), and it can be anticipated that drugs acting at these loci will also become candidates for treating obesity.
Serotoninergic drugs act in at least three ways to facilitate weight loss: They accelerate the onset of satiety (Blundell, 1986), and enhance basal metabolic rate by about 100 calories per day (Fernstrom, 1989). They also inhibit the “carbohydrate craving” manifested by many people who are overweight or are becoming so (c.f., Wurtman and Wurtman, 1989). There is reason to believe that this inappropriate eating behavior actually constitutes a “serotonin hunger” by the brain, perhaps related to the number or activity of raphe neurons, in which case giving the serotoninergic drug might constitute a specific therapy for the etiologic process causing the obesity.
KeywordsBrain Serotonin Serotonin Release Serotonin Synthesis Tryptophan Level Seasonal Affective Disorder
Unable to display preview. Download preview PDF.
- Blundell J.E., 1986, Serotonin manipulations and the structure of feeding behavior, Appetite. (suppl): 39–56.Google Scholar
- Brzezinski A. A, Wurtman J.J., Wurtman R.J., Gleason R., Nader T., and Laferrere B., 1990, d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual syndrome, Obstet. Gynecol. 76:296.Google Scholar
- Fernstrom J.D. and Wurtman R.J.,. 1971 a, Brain serotonin content: Physiological dependence on plasma tryptophan levels, Science 173:149.Google Scholar
- Fernstrom J.D. and Wurtman R.J., 1971 b, Brain serotonin content: Increase following ingestion of carbohydrate diet, Science174: 1023.Google Scholar
- Fernstrom J.D., Wurtman R.J., Hammarstrom-Wiklund B., Rand W.M., Munro H.N. and Davidson C.S., 1979, Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: Effect of dietary protein intake, Am. J. Clin. Nutr.32: 1912.Google Scholar
- Kim W., Kelay J.,Judd J., Marshall M.W., Metz W. and Prather E.S., 1987, Evaluation of long-term dietary intakes of adults consuming self-selected diets, Am. J. Clin. Nutr.40: 1327.Google Scholar
- Leibowitz S.F., Weiss G.F. and Shor-Posner G., 1988, Hypothalamic serotonin: Pharmacological, biochemical and behavioral analyses of its feeding-suppressive action, Clin. Neuropharmacol.11. S51.Google Scholar
- McCue H., Jr., 1981, The 1979 build and blood pressure study, in: “Medical Aspects of Mortality Statistics”, H. Bostrom, N. Ljungstedt, eds., Almquist and Wiksell International, Stockholm.Google Scholar
- Pi-Sunyer F., 1991, Health implications of obesity, Am. J. Clin. Nutr. 53: 1595S.Google Scholar
- Rosenthal N.E., Sack D.A.,Gillin J.C, Lewey A.J., Goodwin F.K., Davenport Y., Mueller P.S., Newsome D.A., and Wehr T.A., 1984, Seasonal Affective Disorder: A description of the syndrome and preliminary findings with light therapy, Arch. Gen. Psychiatry41. 72.Google Scholar
- Schuster C.R., Lewis M. and Seiden L.S., 1986, Fenfluramine neurotoxicity, Psychopharmacol. Bull.22: 148.Google Scholar
- Toornvliet A.C., Pijl H., Hopman E., Pietero M. and Meinders A.E., 1994, The identification of obese patients sensitive to a serotoninergic drug, Abstract Presented at the 7th International Congress on Obesity, Toronto, Canada, August 20 - 25.Google Scholar
- Trouvin J.H,. Gardier A.M, Chanut E., Pages N. and Jacquot C., 1993, Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat, Life Sci. 52: 187.Google Scholar
- Wack J. and Rodin J., 1982, Smoking and its effect on body weight and the systems of caloric regulation, Am. J. Clin. Nutr.35: 366.Google Scholar
- Wurtman J. J., Wurtman R.J., Reynolds S., Tsay R., and Chew B., 1987, d-Fenfluramine suppresses snack intake among carbohydrate cravers but not among non carbohydrate cravers, Int. J. of Eating Disord. 6:687.Google Scholar
- Wurtman R.J. and Wurtman J.J., 1989, Carbohydrates and depression, Sci. Am. January: 68–75.Google Scholar